Evaluation and Selection of the Inhaler Device for Treprostinil Palmitil Inhalation Powder
Treprostinil palmitil (TP) is a prodrug of treprostinil that has been formulated as an inhaled powder, termed TPIP, for evaluation in patients with pulmonary arterial hypertension. In these characterization studies we investigated the aerosol performance of TPIP in response to changes in capsule fil...
Saved in:
Main Authors: | Helena Gauani (Author), Thomas Baker (Author), Zhili Li (Author), Vladimir S. Malinin (Author), Walter Perkins (Author), Eugene Sullivan (Author), David Cipolla (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effect of Inhalation Profile on Delivery of Treprostinil Palmitil Inhalation Powder
by: Helena Gauani, et al.
Published: (2023) -
Preclinical Investigation of a Lipoglycopeptide Dry Powder Inhalation Therapy for the Treatment of Pulmonary MRSA Infection
by: Donna M. Konicek, et al.
Published: (2023) -
Inhaled treprostinil: a therapeutic review
by: Channick RN, et al.
Published: (2012) -
Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements
by: Sabrina Magramane, et al.
Published: (2023) -
Inhaled nicotine replacement therapy
by: David Cipolla, et al.
Published: (2015)